APA (7th ed.) Citation

Mori, K., Yamasaki, K., Morimoto, Y., Kinoshita, T., Asai, S., Arai, T., . . . Hanazawa, T. (2022). Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution. Life (2075-1729), 12(11), 1685. https://doi.org/10.3390/life12111685

Chicago Style (17th ed.) Citation

Mori, Kosei, Kazuki Yamasaki, Yuki Morimoto, Takashi Kinoshita, Shunichi Asai, Tomoyuki Arai, Tomohisa Iinuma, Syuji Yonekura, and Toyoyuki Hanazawa. "Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma Ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution." Life (2075-1729) 12, no. 11 (2022): 1685. https://doi.org/10.3390/life12111685.

MLA (9th ed.) Citation

Mori, Kosei, et al. "Noteworthy Factors to Decide Therapeutic Strategy for Carcinoma Ex Pleomorphic Adenoma of Parotid Gland: A Preliminary Study Statistical Analysis of 22 Cases from Single Institution." Life (2075-1729), vol. 12, no. 11, 2022, p. 1685, https://doi.org/10.3390/life12111685.